SANUWAVE Health announces preliminary Q2 2025 revenue of $10.1-10.2M, up 41-42% YoY

SANUWAVE Health, Inc.

2025-Q2 EPS reported -$0.54 vs consensus -$0.09 ▼ miss (-508.8%)

Preliminary Q2 2025 revenue $10.1-10.2M, increase 41-42% over Q2 2024.
First half 2025 revenue up 50-51% vs first half 2024.
Revenue within range of guidance provided in Q1 2025 earnings release.
CEO Morgan Frank notes sales team expanded to 13, covering all national territories for first time.
Full Q2 results expected on or around August 8, 2025.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.